Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Le Teuff G, Cozic N, Boyer JC, Boige V, Diasio RB, Taieb J, Meulendijks D, Palles C, Schwab M, Deenen M, Largiadèr CR, Marinaki A, Jennings BA, Wettergren Y, Di Paolo A, Gross E, Budai B, Ackland SP, van Kuilenburg ABP, McLeod HL, Milano G, Thomas F, Loriot MA, Kerr D, Schellens JHM, Laurent-Puig P, Shi Q, Pignon JP, Etienne-Grimaldi MC, FUSAFE collaborative group

Open source

DOI: 10.1038/s41416-023-02517-2
Published: 2024 Mar
Container: British journal of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41416-023-02517-2,
  title = {Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.},
  author = {Le Teuff G and Cozic N and Boyer JC and Boige V and Diasio RB and Taieb J and Meulendijks D and Palles C and Schwab M and Deenen M and Largiadèr CR and Marinaki A and Jennings BA and Wettergren Y and Di Paolo A and Gross E and Budai B and Ackland SP and van Kuilenburg ABP and McLeod HL and Milano G and Thomas F and Loriot MA and Kerr D and Schellens JHM and Laurent-Puig P and Shi Q and Pignon JP and Etienne-Grimaldi MC and FUSAFE collaborative group},
  year = {2024},
  journal = {British journal of cancer},
  doi = {10.1038/s41416-023-02517-2},
  url = {https://doi.org/10.1038/s41416-023-02517-2}
}

RIS

TY  - JOUR
TI  - Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
AU  - Le Teuff G
AU  - Cozic N
AU  - Boyer JC
AU  - Boige V
AU  - Diasio RB
AU  - Taieb J
AU  - Meulendijks D
AU  - Palles C
AU  - Schwab M
AU  - Deenen M
AU  - Largiadèr CR
AU  - Marinaki A
AU  - Jennings BA
AU  - Wettergren Y
AU  - Di Paolo A
AU  - Gross E
AU  - Budai B
AU  - Ackland SP
AU  - van Kuilenburg ABP
AU  - McLeod HL
AU  - Milano G
AU  - Thomas F
AU  - Loriot MA
AU  - Kerr D
AU  - Schellens JHM
AU  - Laurent-Puig P
AU  - Shi Q
AU  - Pignon JP
AU  - Etienne-Grimaldi MC
AU  - FUSAFE collaborative group
PY  - 2024
JO  - British journal of cancer
DO  - 10.1038/s41416-023-02517-2
UR  - https://doi.org/10.1038/s41416-023-02517-2
ER  -

APA

G, L. T., N, C., JC, B., V, B., RB, D., J, T., D, M., C, P., M, S., M, D., CR, L., A, M., BA, J., Y, W., A, D. P., E, G., B, B., SP, A., ABP, V. K., HL, M., G, M., F, T., MA, L., D, K., JHM, S., P, L., Q, S., JP, P., MC, E., & group, F. C. (2024). Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.. British journal of cancer. https://doi.org/10.1038/s41416-023-02517-2

Source records

pubmed · retrieved 2026-09-27T08:17:47.566Z